Metabolic and hemostatic effects of 2 low dose oral contraceptives (OCs), a triphasic (ethinylestradiol +( - )-norgestrel) and a monophasic (ethinylestradiol + desogestrel) preparation, were compared in a cross-over trial in fertile women over 35 years of age. Both combinations moderately affected plasma lipids, with 17-24% increases of total triglyceridemia. Triglycerides accumulate in low density lipoproteins, thus suggesting the possible formation of an atherogenic lipoprotein particle. Only the monophasic preparation increased high density lipoprotein (HDL)-cholesterol levels significantly, with a rise in HDL3 mass and cholesterol. OC treatment led to slight changes in HDL2 and HDL3 structure, with a rise of the cholesteryl ester and triglyceride contents, indicative of a stimulated cholesterol esterification and reverse transport. Changes in the hemostatic indexes (fibrinogen, antithrombin III and protein C) were negligible. The new low dose OCs, even when prescribed to relatively older women, affect to a relatively small extent lipid/lipoprotein metabolism, with the exception of changes in the low density lipoprotein composition.

COMPARISON OF THE LIPOPROTEIN AND HEMOSTATIC CHANGES AFTER A TRIPHASIC AND A MONOPHASIC LOW-DOSE ORAL-CONTRACEPTIVE IN PREMENOPAUSAL MIDDLE-AGED WOMEN / C. SIRTORI, L. CALABRESI, G. FRANCESCHINI, G. GIANFRANCESCHI, F. ZOPPI, S. WINKLER, P. BILOTTA, A. ZAMPETTI. - In: ATHEROSCLEROSIS. - ISSN 0021-9150. - 84:2-3(1990), pp. 203-211.

COMPARISON OF THE LIPOPROTEIN AND HEMOSTATIC CHANGES AFTER A TRIPHASIC AND A MONOPHASIC LOW-DOSE ORAL-CONTRACEPTIVE IN PREMENOPAUSAL MIDDLE-AGED WOMEN

C. SIRTORI
Primo
;
L. CALABRESI
Secondo
;
G. FRANCESCHINI;
1990

Abstract

Metabolic and hemostatic effects of 2 low dose oral contraceptives (OCs), a triphasic (ethinylestradiol +( - )-norgestrel) and a monophasic (ethinylestradiol + desogestrel) preparation, were compared in a cross-over trial in fertile women over 35 years of age. Both combinations moderately affected plasma lipids, with 17-24% increases of total triglyceridemia. Triglycerides accumulate in low density lipoproteins, thus suggesting the possible formation of an atherogenic lipoprotein particle. Only the monophasic preparation increased high density lipoprotein (HDL)-cholesterol levels significantly, with a rise in HDL3 mass and cholesterol. OC treatment led to slight changes in HDL2 and HDL3 structure, with a rise of the cholesteryl ester and triglyceride contents, indicative of a stimulated cholesterol esterification and reverse transport. Changes in the hemostatic indexes (fibrinogen, antithrombin III and protein C) were negligible. The new low dose OCs, even when prescribed to relatively older women, affect to a relatively small extent lipid/lipoprotein metabolism, with the exception of changes in the low density lipoprotein composition.
(-)-Norgestrel; Desogestrel; High density lipoprotein subfractions; Low density lipoproteins; Oral contraceptives; Thrombosis
Settore BIO/14 - Farmacologia
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/187815
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 14
social impact